On January 15, 2025, the U.S. Department of Health and Human Services Office of Inspector General (“OIG”) posted Advisory Opinion 25-01, a favorable opinion analyzing a pharmaceutical manufacturer’s ...
Patients with retinal diseases who were treated with anti-VEGF therapies through manufacturer patient assistance programs ...
You may qualify for free Restasis through the drug’s manufacturer, myAbbVie Assist. That said, you won’t use your Medicare coverage. Restasis (cyclosporine), a brand-name eye drop for chronic dry eyes ...
Limited evidence from a literature review suggests that co-pay assistance was associated with improved treatment persistence/adherence across various diseases, with indirect evidence suggesting ...
Associations of Financial Hardship and Health Status, Social Functioning, and Mental Health Among Cancer Survivors in the United States: Findings From a Nationally Representative Study Ulman ...
Pilot Study of a Mobile Phone Chatbot for Medication Adherence and Toxicity Management Among Patients With GI Cancers on Capecitabine Oral anticancer medications (OAMs) are high priced with a ...
Leemore Dafny ([email protected]), Harvard University, Boston, Massachusetts. Christopher Ody, Northwestern University, Evanston, Illinois. Teresa Rokos, University ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results